Papp L Roy & Associates decreased its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,924 shares of the pharmacy operator’s stock after selling 1,005 shares during the quarter. Papp L Roy & Associates’ holdings in Walgreens Boots Alliance were worth $1,461,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also recently bought and sold shares of WBA. Hudock Capital Group LLC lifted its position in Walgreens Boots Alliance by 0.5% during the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 6 shares during the period. Westside Investment Management Inc. lifted its position in Walgreens Boots Alliance by 10.4% during the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after purchasing an additional 125 shares during the period. IHT Wealth Management LLC lifted its position in Walgreens Boots Alliance by 46.3% during the second quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 2,199 shares during the period. Bristlecone Advisors LLC bought a new position in Walgreens Boots Alliance during the third quarter valued at approximately $135,000. Finally, Private Vista LLC lifted its position in Walgreens Boots Alliance by 6,403.7% during the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock valued at $140,000 after purchasing an additional 574,218 shares during the period. Hedge funds and other institutional investors own 61.18% of the company’s stock.
In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director John Anthony Lederer purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by insiders.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business had revenue of $30.15 billion during the quarter, compared to analysts’ expectations of $29.93 billion. During the same period last year, the company posted $1.07 EPS. The business’s revenue was up 5.3% on a year-over-year basis. sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current fiscal year.
Walgreens Boots Alliance declared that its board has approved a share repurchase program on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback programs are often an indication that the company’s management believes its shares are undervalued.
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were paid a dividend of $0.40 per share. The ex-dividend date was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.20%. Walgreens Boots Alliance’s dividend payout ratio is presently 42.33%.
Several research analysts have weighed in on WBA shares. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, August 30th. Jefferies Group reiterated a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research report on Sunday, September 10th. Royal Bank of Canada started coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price target on the stock. Finally, Raymond James Financial reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Wednesday, September 27th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. Walgreens Boots Alliance has an average rating of “Buy” and a consensus target price of $86.89.
TRADEMARK VIOLATION WARNING: This news story was first posted by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at https://www.com-unik.info/2017/12/25/walgreens-boots-alliance-inc-wba-stake-lowered-by-papp-l-roy-associates.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.